7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Lung Neoplasms D008175 171 associated lipids
Wounds and Injuries D014947 20 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Fu YX et al. Osteoprotegerin influences the bone resorption activity of osteoclasts. 2013 Int. J. Mol. Med. pmid:23563320
Xu L et al. Effects of cell surface α2-3 sialic acid on osteogenesis. 2013 Glycoconj. J. pmid:23519914
Çankaya M et al. The effects of chronic zoledronate usage on the jaw and long bones evaluated using RANKL and osteoprotegerin levels in an animal model. 2013 Int J Oral Maxillofac Surg pmid:23522850
Pichler K et al. RANKL is downregulated in bone cells by physical activity (treadmill and vibration stimulation training) in rat with glucocorticoid-induced osteoporosis. 2013 Histol. Histopathol. pmid:23553492
Kwon H et al. Effect of 635 nm irradiation on high glucose-boosted inflammatory responses in LPS-induced MC3T3-E1 cells. 2013 Lasers Med Sci pmid:22699799
Tantikanlayaporn D et al. A diarylheptanoid phytoestrogen from Curcuma comosa, 1,7-diphenyl-4,6-heptadien-3-ol, accelerates human osteoblast proliferation and differentiation. 2013 Phytomedicine pmid:23557993
Fuernau G et al. Osteoprotegerin in ST-elevation myocardial infarction: prognostic impact and association with markers of myocardial damage by magnetic resonance imaging. 2013 Int. J. Cardiol. pmid:22704876
Rakic M et al. Bone loss biomarkers associated with peri-implantitis. A cross-sectional study. 2013 Clin Oral Implants Res pmid:22708989
Kadow-Romacker A et al. Effect of β-tricalcium phosphate coated with zoledronic acid on human osteoblasts and human osteoclasts in vitro. 2013 J Biomater Appl pmid:21862509
Weiss RM et al. Osteoprotegerin inhibits aortic valve calcification and preserves valve function in hypercholesterolemic mice. 2013 PLoS ONE pmid:23762316
Ding Q and Zhang FQ [Effect of icariin on the expression of receptor activator nuclear factor-κB ligand and osteoprotegerin of human periodontal ligament cells]. 2013 Zhonghua Kou Qiang Yi Xue Za Zhi pmid:23714056
Okamura H et al. Protein phosphatase 2A Cα is involved in osteoclastogenesis by regulating RANKL and OPG expression in osteoblasts. 2013 FEBS Lett. pmid:23183242
Silva HC et al. Higher prevalence of morphometric vertebral fractures in patients with recent coronary events independently of BMD measurements. 2013 Bone pmid:23142805
Tecilazich F et al. Postexercise phosphocreatine recovery, an index of mitochondrial oxidative phosphorylation, is reduced in diabetic patients with lower extremity complications. 2013 J. Vasc. Surg. pmid:23465172
Loiselle AE et al. Inhibition of GSK-3β rescues the impairments in bone formation and mechanical properties associated with fracture healing in osteoblast selective connexin 43 deficient mice. 2013 PLoS ONE pmid:24260576
Ye Z et al. Associations of candidate biomarkers of vascular disease with the ankle-brachial index and peripheral arterial disease. 2013 Am. J. Hypertens. pmid:23467205
Fekete S et al. The effect of levetiracetam on rat bone mass, structure and metabolism. 2013 Epilepsy Res. pmid:24035343
He T et al. Multiple biomarkers analysis for the early detection of prosthetic aseptic loosening of hip arthroplasty. 2013 Int Orthop pmid:23467893
Song JF et al. Association between single nucleotide polymorphisms of the osteoprotegerin gene and postmenopausal osteoporosis in Chinese women. 2013 Genet. Mol. Res. pmid:24065669
Lin C et al. The C-terminal region Mesd peptide mimics full-length Mesd and acts as an inhibitor of Wnt/β-catenin signaling in cancer cells. 2013 PLoS ONE pmid:23469146
Wu LZ et al. Nicotine favors osteoclastogenesis in human periodontal ligament cells co-cultured with CD4(+) T cells by upregulating IL-1β. 2013 Int. J. Mol. Med. pmid:23443505
Prati AJ et al. Release of bone markers in immediately loaded and nonloaded dental implants: a randomized clinical trial. 2013 J. Dent. Res. pmid:24158337
Kim HR et al. Serum osteoprotegerin level is associated with degree of arteriovenous fistula stenosis in patients with hemodialysis. 2013 Clin. Nephrol. pmid:24091316
Xiong Q et al. [Effects of recombinant human osteoprotegerin and recombinant RANK protein on the differentiation of osteoclast precursors]. 2013 Zhongguo Gu Shang pmid:23844495
Kovács G et al. [Metabolic differences in healthy first-degree female relatives of type 2 diabetic patients]. 2013 Orv Hetil pmid:24161599
Zhang PF et al. Interrelationship of circulating matrix metalloproteinase-9, TNF-α, and OPG/RANK/RANKL systems in COPD patients with osteoporosis. 2013 COPD pmid:23845033
Jiang W et al. Identification of five serum protein markers for detection of ovarian cancer by antibody arrays. 2013 PLoS ONE pmid:24116163
Riesco M et al. Osteoporosis in psoriatic arthritis: an assessment of densitometry and fragility fractures. 2013 Clin. Rheumatol. pmid:23846386
Canalis E et al. Notch signaling in osteocytes differentially regulates cancellous and cortical bone remodeling. 2013 J. Biol. Chem. pmid:23884415
Szymczak J and Bohdanowicz-Pawlak A Osteoprotegerin, RANKL, and bone turnover in primary hyperparathyroidism: the effect of parathyroidectomy and treatment with alendronate. 2013 Horm. Metab. Res. pmid:23888411
Gordin D et al. Osteoprotegerin is an independent predictor of vascular events in Finnish adults with type 1 diabetes. 2013 Diabetes Care pmid:23801795
Galeone A et al. Activation of the receptor activator of the nuclear factor-κB ligand pathway during coronary bypass surgery: comparison between on- and off-pump coronary artery bypass surgery procedures. 2013 Eur J Cardiothorac Surg pmid:23671202
Xi L et al. OPG/RANK/RANKL axis in stabilization of spontaneously restored sinus rhythm in permanent atrial fibrillation patients after mitral valve surgery. 2013 Cardiology pmid:23295350
Steinmetz M et al. Atorvastatin-induced increase in progenitor cell levels is rather caused by enhanced receptor activator of NF-kappaB ligand (RANKL) cell proliferation than by bone marrow mobilization. 2013 J. Mol. Cell. Cardiol. pmid:23295770
Eleftheriadis T et al. Serum osteoprotegerin is markedly increased and may contribute to decreased blood T cell count in hemodialysis patients. 2013 Int Urol Nephrol pmid:23296793
dos Santos PL et al. Guided implant surgery: what is the influence of this new technique on bone cell viability? 2013 J. Oral Maxillofac. Surg. pmid:23298799
Hoy J et al. Interruption or deferral of antiretroviral therapy reduces markers of bone turnover compared with continuous therapy: The SMART body composition substudy. 2013 J. Bone Miner. Res. pmid:23299909
Saito K et al. Conditional inactivation of TNFα-converting enzyme in chondrocytes results in an elongated growth plate and shorter long bones. 2013 PLoS ONE pmid:23349978
Kelesidis T et al. Perturbations of circulating levels of RANKL-osteoprotegerin axis in relation to lipids and progression of atherosclerosis in HIV-infected and -uninfected adults: ACTG NWCS 332/A5078 Study. 2013 AIDS Res. Hum. Retroviruses pmid:23351153
Jimi E et al. The RANKL/RANK system as a therapeutic target for bone invasion by oral squamous cell carcinoma (Review). 2013 Int. J. Oncol. pmid:23354319
Kebschull M et al. Mobilization of endothelial progenitors by recurrent bacteremias with a periodontal pathogen. 2013 PLoS ONE pmid:23355901
Velusamy SK et al. Lactoferrin knockout mice demonstrates greater susceptibility to Aggregatibacter actinomycetemcomitans-induced periodontal disease. 2013 J. Periodontol. pmid:23327622
Gümüş P et al. Gingival crevicular fluid, serum levels of receptor activator of nuclear factor-κB ligand, osteoprotegerin, and interleukin-17 in patients with rheumatoid arthritis and osteoporosis and with periodontal disease. 2013 J. Periodontol. pmid:23327689
Pei Z et al. Effect of icariin on cell proliferation and the expression of bone resorption/formation-related markers in human periodontal ligament cells. 2013 Mol Med Rep pmid:24065204
Olivares-Navarrete R et al. Rough titanium alloys regulate osteoblast production of angiogenic factors. 2013 Spine J pmid:23684238
Ney JT et al. Genetic polymorphism of the OPG gene associated with breast cancer. 2013 BMC Cancer pmid:23369128
Milone F et al. Assessment and clinical implications of RANK/RANKL/OPG pathway as markers of bone tumor progression in patients with NET harboring bone metastases. 2013 Biomarkers pmid:23336103
Cao H et al. Osteoprotegerin/RANK/RANKL axis and atrial remodeling in mitral valvular patients with atrial fibrillation. 2013 Int. J. Cardiol. pmid:22178057
Zhang ZG et al. Therapeutic effect of aqueous extract from Ecliptae herba on bone metabolism of ovariectomized rats. 2013 Menopause pmid:23096243
Bosselut N et al. Including osteoprotegerin and collagen IV in a score-based blood test for liver fibrosis increases diagnostic accuracy. 2013 Clin. Chim. Acta pmid:23022619

Table of Content